TY - JOUR
T1 - 6-gingerol as an antioxidant to ameliorate kidney injury in high-fat high-fructose diet-induced metabolic syndrome in rats
AU - Wulandari, Endah
AU - Andri, Salsabila Amanda Putri
AU - Soetikno, Vivian
AU - Kusmardi,
AU - Louisa, Melva
AU - Gunawan, Shirly
AU - Arumugam, Somasundaram
N1 - Publisher Copyright:
© 2025 Endah Wulandari et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
PY - 2025
Y1 - 2025
N2 - The aim of this study is to investigate the impact of 6-gingerol (6-G) on oxidative stress in high-fat high-fructose (HFHF) diet-induced metabolic syndrome (MetS) in rats. Male Sprague-Dawley rats were randomly divided into five groups (n = 5). The control group received a standard diet. The MetS group received the HFHF diet for 16 weeks and, at Week 8, received a single dose of streptozotocin at 22 mg/kg body weight (b.w.). After eight weeks of HFHF diet feeding, the rats were dosed orally with 6-G (50, 100, or 200 mg/kg/day) once daily for another eight weeks. Urine samples were collected for N-acetyl-β-D-glucosaminidase (NAG) and creatinine analysis, whereas kidney tissue was obtained for histological evaluation and quantitative real-time polymerase chain reaction studies for p47phox, p67phox, NOX2, and NOX4. At the end of the study, the urine NAG/creatinine ratio was significantly decreased in the 6-G groups at all three doses. The 6-G treatment at all three doses markedly suppressed messenger RNA expression of p47phox, p67phox, NOX2, and NOX4. This was associated with a substantial decrease in tubulointerstitial inflammatory cells, fibrotic area, and lipid droplets in rats receiving the HFHF diet and 6-G Treatment. 6-G could attenuate MetS-induced kidney injury via anti-oxidant activity, leading to improved kidney damage.
AB - The aim of this study is to investigate the impact of 6-gingerol (6-G) on oxidative stress in high-fat high-fructose (HFHF) diet-induced metabolic syndrome (MetS) in rats. Male Sprague-Dawley rats were randomly divided into five groups (n = 5). The control group received a standard diet. The MetS group received the HFHF diet for 16 weeks and, at Week 8, received a single dose of streptozotocin at 22 mg/kg body weight (b.w.). After eight weeks of HFHF diet feeding, the rats were dosed orally with 6-G (50, 100, or 200 mg/kg/day) once daily for another eight weeks. Urine samples were collected for N-acetyl-β-D-glucosaminidase (NAG) and creatinine analysis, whereas kidney tissue was obtained for histological evaluation and quantitative real-time polymerase chain reaction studies for p47phox, p67phox, NOX2, and NOX4. At the end of the study, the urine NAG/creatinine ratio was significantly decreased in the 6-G groups at all three doses. The 6-G treatment at all three doses markedly suppressed messenger RNA expression of p47phox, p67phox, NOX2, and NOX4. This was associated with a substantial decrease in tubulointerstitial inflammatory cells, fibrotic area, and lipid droplets in rats receiving the HFHF diet and 6-G Treatment. 6-G could attenuate MetS-induced kidney injury via anti-oxidant activity, leading to improved kidney damage.
KW - diet
KW - gingerol
KW - insulin resistance
KW - kidney diseases
KW - lipid accumulation
KW - Oxidants
UR - http://www.scopus.com/inward/record.url?scp=85211450771&partnerID=8YFLogxK
U2 - 10.7324/JAPS.2024.184247
DO - 10.7324/JAPS.2024.184247
M3 - Article
AN - SCOPUS:85211450771
SN - 2231-3354
VL - 15
SP - 72
EP - 80
JO - Journal of Applied Pharmaceutical Science
JF - Journal of Applied Pharmaceutical Science
IS - 1
ER -